Yasuki Yamada

(1<i>S</i>)-1-[(4<i>R</i>)-2,2-Dimethyl-1,3-dioxolan-4-yl]-2-hydroxyethylammonium Benzoate, A Versatile Building Block for Chiral 2-Aminoalkanols:  Concise Synthesis and Application to Nelfinavir, a Potent HIV-Protease Inhibitor

Takashi Inaba, Yasuki Yamada, Hiroyuki Abé et al. · The Journal of Organic Chemistry · 2000 · 48 citations

Bioorganic Chemistry, Organic Chemistry, Antiviral Drug +17

Different Effects of Epigenetic Modifiers on the Cytotoxicity Induced by 5-Fluorouracil, Irinotecan or Oxaliplatin in Colon Cancer Cells

Mika Ikehata, Mao Ogawa, Yasuki Yamada et al. · Biological and Pharmaceutical Bulletin · 2013 · 42 citations · Full text

Oncology, Chemoprevention Strategy, Epigenetic Modifiers +14

A Practical Synthesis of Nelfinavir, an HIV-Protease Inhibitor, Using a Novel Chiral C4 Building Block:  (5<i>R</i>,6<i>S</i>)-2,2-Dimethyl-5-hydroxy-1,3-dioxepan-6-ylammonium Acetate

Takashi Inaba, Angela G. Birchler, Yasuki Yamada et al. · The Journal of Organic Chemistry · 1998 · 39 citations

Bioorganic Chemistry, Altmetric Attention Score, Hiv-protease Inhibitor +17

New Class of Corticotropin-Releasing Factor (CRF) Antagonists:  Small Peptides Having High Binding Affinity for CRF Receptor

Yasuki Yamada, Kenji Mizutani, Yasuhiro Mizusawa et al. · Journal of Medicinal Chemistry · 2004 · 28 citations · Full text

Small Peptide, Peptide Science, Hypothalamic Peptide +18

Structure and activity of artificial mutant variants of human growth hormone

Satoshi Nishikawa, Yoshitaka Nishida, Haruki Uemura et al. · Protein Engineering Design and Selection · 1989 · 15 citations